Qure.ai Series B

Qure.ai develops AI-powered solutions that accelerate healthcare by providing actionable insights for pulmonary health, lung cancer, and stroke care. Their WHO-evaluated AI solutions support clinicians in making quick and accurate diagnosis and treatment decisions, impacting over 45 million lives across 105 countries. They also offer AI biomarkers for clinical trials and real-world impact.